Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differences

Johnston, S; Emde, A; Barrios, C; Srock, S; Neven, P; Martin, M; Cameron, D; Janni, W; Gnant, M

Johnston, S (通讯作者)，Royal Marsden NHS Fdn Trust, Breast Unit, Fulham Rd, London SW3 6JJ, England.

JNCI CANCER SPECTRUM, 2023; 7 (4):

Abstract

The cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors palbociclib, ribociclib, and abemaciclib are standard-of-care therapy for hormone receptor-pos......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索